Forest Laboratories(FRX)
Forest Laboratories was a company in the pharmaceutical industry incorporated in Delaware, with its principal office in New York City. It was known for licensing European pharmaceuticals for sale in the United States. On July 1, 2014, the company was acquired by Actavis (now Allergan).
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Ambenyl | Bromodiphenhydramine, Codeine | 1984-01-10 | 2032 | |
| Bancap | Acetaminophen, Hydrocodone, Butalbital | 1983-03-17 | 2025-2039 | |
| Betaprone | Propiolactone | 1982-01-01 | — | |
| Campral | Acamprosate | 2004-07-29 | ||
| Celexa | Citalopram | 1999-12-22 | ||
| Combunox | Ibuprofen, Oxycodone | 2004-11-26 | 2024-2036 | |
| Duradyne dhc | Acetaminophen, Hydrocodone | 1983-03-17 | 2025-2039 | |
| Duraphyl | Theophylline | 1985-04-03 | ||
| Elixicon | Theophylline | 1982-01-01 | ||
| Elixophyllin | Theophylline | 1984-07-31 |
1
2
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use